Literature DB >> 33582129

Change from NAFLD to MAFLD increases the awareness of fatty liver disease in primary care physicians and specialists.

Yasser Fouad1, Ahmed Gomaa2, Nady Semida3, Wael Abdel Ghany3, Dina Attia4.   

Abstract

Entities:  

Year:  2021        PMID： 33582129     DOI： 10.1016/j.jhep.2020.12.035

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  10 in total

1.  Metabolic (dysfunction) associated fatty liver disease: more evidence and a bright future.

Authors:  Ting-Yao Wang; Jacob George; Ming-Hua Zheng
Journal:  Hepatobiliary Surg Nutr       Date:  2021-12       Impact factor: 7.293

2.  Relationship between the Metabolic Associated Fatty Liver Disease and Endometrial Thickness in Postmenopausal Women: A Cross-sectional Study in China.

Authors:  Jia-Ying Wei; Zhou Xu; Hao Li; Wen-Qin Du; Bai-Ling Niu; Shu Li; Shen Tian; Juan Wu; Yu-Ling Chen; Xin Li; Zi-Li Liu; Jun Xiao; Guo-Sheng Ren; Liang Ran; Ling-Quan Kong
Journal:  Int J Med Sci       Date:  2021-06-22       Impact factor: 3.738

Review 3.  Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory Science.

Authors:  Yasser Fouad; Melissa Palmer; Minjun Chen; Arie Regev; Rajarshi Banerjee; Rob Myers; Robert Riccio; Richard Torstenson; Ramy Younes; Puneet S Arora; Henrik Landgren; Morten A Karsdal; Martin Blake; David A Shapiro; Hans-Juergen Gruss; Muhammad Y Sheikh; Dina Attia; Steven Bollipo; Alastair D Smith; Bradley Freilich; Robert G Gish; Detlef Schuppan
Journal:  J Clin Transl Hepatol       Date:  2021-10-22

Review 4.  Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease.

Authors:  Huapeng Lin; Xinrong Zhang; Guanlin Li; Grace Lai-Hung Wong; Vincent Wai-Sun Wong
Journal:  J Clin Transl Hepatol       Date:  2021-08-30

5.  Association of Obstructive Sleep Apnea with Nocturnal Hypoxemia in Metabolic-Associated Fatty Liver Disease Patients: A Cross-sectional Analysis of Record-based Data.

Authors:  Arvind Tomar; Ankit Bhardwaj; Ashok Choudhary; Debajyoti Bhattacharyya
Journal:  J Family Med Prim Care       Date:  2021-08-27

Review 6.  Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update.

Authors:  Jawaher Alharthi; Mohammed Eslam
Journal:  J Clin Transl Hepatol       Date:  2021-10-13

7.  The egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.

Authors:  Yasser Fouad; Gamal Esmat; Reda Elwakil; Serag Zakaria; Ayman Yosry; Imam Waked; Maissa El-Razky; Wahid Doss; Magdy El-Serafy; Ebraheem Mostafa; Mahmood Anees; Mohamed A Sakr; Nadia AbdelAty; Ashraf Omar; Samy Zaki; Amgad Al-Zahaby; Hamdy Mahfouz; Maysaa Abdalla; Mahmoud Albendary; Abdel-Khalek Hamed; Ahmed Gomaa; Adel Hasan; Sherif Abdel-Baky; Medhat El Sahhar; Gamal Shiha; Dina Attia; Ebada Saeed; Enas Kamal; Shamardan Bazeed; Mai Mehrez; Shereen Abdelaleem; Yasmine Gaber; Mohammed Abdallah; Asmaa Salama; Doaa A Tawab; Shaymaa Nafady
Journal:  Saudi J Gastroenterol       Date:  2022 Jan-Feb       Impact factor: 2.485

Review 8.  MAFLD enhances clinical practice for liver disease in the Asia-Pacific region.

Authors:  Takumi Kawaguchi; Tsubasa Tsutsumi; Dan Nakano; Mohammed Eslam; Jacob George; Takuji Torimura
Journal:  Clin Mol Hepatol       Date:  2021-11-10

9.  Swertia mussotii prevents high-fat diet-induced non-alcoholic fatty liver disease in rats by inhibiting expression the TLR4/MyD88 and the phosphorylation of NF-κB.

Authors:  Ming Dong Si; Meng Wu; Xi Zhen Cheng; Zhi Hong Ma; Yu Guang Zheng; Jing Li; Si Li; Yong Xing Song; Donglai Ma
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

10.  Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD).

Authors:  Nahum Méndez-Sánchez; Luis Enrique Díaz-Orozco
Journal:  Med Sci Monit       Date:  2021-07-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.